Sign in or Register

Human EGFR Phosphorylation Antibody Array (Membrane, 17 Targets) (Y0044) (AbAr-0044-YC)

Antibody array is a specific form of protein microarray. In this technology, capture antibodies spotted on membranes or glass slide bind to specific target proteins present in the sample. Captured proteins are visualized using chemiluminescent or Laser Scanner. The signal produced is proportional to the amount of analyte bound. The Human EGFR Phosphorylation Antibody Array detects 17 site specific and pan Human EGFRs. It is suitable for all liquid sample types but intended for use with cell and tissue lysates.
Target Array
EGFR Phosphorylation Array
EGFR (P-Tyr845), EGFR (P-Tyr1148), ErbB2 (P-Tyr1112), ErbB3 (P-Tyr1289), EGFR (P-Tyr992), EGFR (P-Tyr1173), ErbB2 (P-Tyr 1221/1222), ErbB4 (P-Tyr1284), EGFR (P-Tyr1045), EGFR (P-Ser1046/1047), ErbB2 (P-Tyr1248), EGFR (P-Tyr1068), EGFR (P-Ser1070), ErbB2 (P-Thr686), EGFR (P-Tyr1086), ErbB2 (P-Tyr877), ErbB2 (P-Ser1113)
Species Reactivity
Sample Type
Serum, Plasma, Cell Culture Supernatant, Cell Lysates, Tissue Lysates
Multiplex Protein Detection
Assay Type
Solid Support
Detection Assay
Protocol Outline
Block membranes
Incubate with Sample
Incubate with Biotinylated Detection Antibody Cocktail
Incubate with HRP-Conjugated Streptavidin
Incubate with Detection Buffers
Image with chemiluminescent imaging system
Perform densitometry and analysis
Antibody Array Membrane
Labeling Reagent
Blocking Buffer
Wash Buffer
Detection Buffer
Detection Cocktail
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Once thawed, please keep reagents under suitable conditions respectively. Do not use past expiration date.
The epidermal growth factor receptor is a transmembrane protein that is a receptor for members of the epidermal growth factor family (EGF family) of extracellular protein ligands. The epidermal growth factor receptor is a member of the ErbB family of receptors, a subfamily of four closely related receptor tyrosine kinases: EGFR (ErbB-1), HER2/neu (ErbB-2), Her 3 (ErbB-3) and Her 4 (ErbB-4). In many cancer types, mutations affecting EGFR expression or activity could result in cancer. Deficient signaling of the EGFR and other receptor tyrosine kinases in humans is associated with diseases such as Alzheimer's, while over-expression is associated with the development of a wide variety of tumors. Interruption of EGFR signalling, either by blocking EGFR binding sites on the extracellular domain of the receptor or by inhibiting intracellular tyrosine kinase activity, can prevent the growth of EGFR-expressing tumours and improve the patient's condition.
Ask a question We look forward to hearing from you.
0 reviews or Q&As
Submit a review Submit a review and you will get a coupon.
0 reviews
For Research Use Only. Not For Clinical Use.